Patient Derived Xenografts Expand Human Primary Pancreatic Tumor Tissue Availability for ex vivo Irreversible Electroporation Testing
New methods of tumor ablation have shown exciting efficacy in pre-clinical models but often demonstrate limited success in the clinic. Due to a lack of quality or quantity in primary malignant tissue specimens, therapeutic development and optimization studies are typically conducted on healthy tissu...
Main Authors: | Rebecca M. Brock, Natalie Beitel-White, Sheryl Coutermarsh-Ott, Douglas J. Grider, Melvin F. Lorenzo, Veronica M. Ringel-Scaia, Navid Manuchehrabadi, Robert C. G. Martin, Rafael V. Davalos, Irving C. Allen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00843/full |
Similar Items
-
Starting a Fire Without Flame: The Induction of Cell Death and Inflammation in Electroporation-Based Tumor Ablation Strategies
by: Rebecca M. Brock, et al.
Published: (2020-07-01) -
A Patient-specific Irreversible Electroporation Treatment Planning Model Based on Human Tissue Properties
by: White, Natalie B.
Published: (2018) -
Uncertainty Quantification in Irreversible Electroporation Simulations
by: Nicholas Labarbera
Published: (2017-05-01) -
Irreversible Electroporation for Prostate Cancer
by: Sean Ong, et al.
Published: (2021-05-01) -
Irreversible electroporation of hepatocellular carcinoma: the role of ultrasonography
by: Katsutoshi Sugimoto, et al.
Published: (2020-07-01)